l e t t e r s
Primary aldosteronism is the most prevalent form of secondary hypertension. To explore molecular mechanisms of autonomous aldosterone secretion, we performed exome sequencing of aldosterone-producing adenomas (APAs). We identified somatic hotspot mutations in the ATP1A1 (encoding an Na + /K + ATPase a subunit) and ATP2B3 (encoding a Ca 2+ ATPase) genes in three and two of the nine APAs, respectively. These ATPases are expressed in adrenal cells and control sodium, potassium and calcium ion homeostasis. Functional in vitro studies of ATP1A1 mutants showed loss of pump activity and strongly reduced affinity for potassium. Electrophysiological ex vivo studies on primary adrenal adenoma cells provided further evidence for inappropriate depolarization of cells with ATPase alterations. In a collection of 308 APAs, we found 16 (5.2%) somatic mutations in ATP1A1 and 5 (1.6%) in ATP2B3. Mutation-positive cases showed male dominance, increased plasma aldosterone concentrations and lower potassium concentrations compared with mutationnegative cases. In summary, dominant somatic alterations in two members of the ATPase gene family result in autonomous aldosterone secretion.
Excessive autonomous aldosterone secretion by the adrenal gland, called primary aldosteronism, causes drug-resistant and often lifethreatening arterial hypertension accompanied by severe hypokalemia. Long-term consequences include higher risk of stroke, myocardial infarction and atrial fibrillation. Primary aldosteronism is present in up to 7% of hypertensive individuals in population-based studies 1 and in up to 20% of individuals with therapy resistance referred to specialized centers 2 . Primary aldosteronism can be caused by bilateral adrenal hyperplasia or a unilateral APA. Depending on the population and applied diagnostic procedures, the proportion of primary aldosteronism cases with APA can be as high as 60% (ref. 3) . Recent reports identified mutations in the potassium channel gene KCNJ5 as a cause of familial and sporadic forms of primary aldosteronism and estimated the proportion of APAs caused by KCNJ5 mutations at 30-40% (refs. 4,5) .
To identify further genetic determinants of primary aldosteronism, we performed exome sequencing in tumor and matched control tissue from nine males affected by hypokalemic primary aldosteronism without somatic KCNJ5 mutations (Supplementary Table 1) . Sequencing identified a low number of protein-altering mutations (0-13 per adenoma; mean of 4.1 ± 1.4; Supplementary Table 2) . Notably, within this small set of genetic alterations, we found multiple somatic variants in two members of the P-type ATPase gene family, ATP1A1 (encoding an Na + /K + ATPase a subunit) and ATP2B3 (encoding the plasma membrane Ca 2+ ATPase). Missense variants in ATP1A1 (NM_000701.7) were present in three out of nine adenomas (c.311T>G in two cases and c.995T>G in one case), leading to p.Leu104Arg and p.Val332Gly substitutions, respectively. In-frame deletions of ATP2B3 (NM_021949.3) were present in two adenomas (c.1272_1277delGCTGGT and c.1273_1278delCTGGTC), in both Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension l e t t e r s instances resulting in deletion of two amino acids at positions 425 and 426 (p.Leu425_Val426del; Fig. 1 ). Sequence comparisons showed that the affected amino acids are highly conserved among species as well as among different members of the P-type ATPase family (Supplementary Fig. 1 ).
We next sequenced the entire coding regions of ATP1A1 and ATP2B3 in 100 additional adenomas (Supplementary Table 3 ) and identified 6 further somatic mutations in ATP1A1 and 2 in ATP2B3. Four of the ATP1A1 mutations occurred at the same nucleotide position (c.311T>G), and two deletions including position 311 led to an in-frame deletion of five amino acids (c.299_313delTCTCAATGT-TACTGT; p.Phe100_Leu104del). Two adenomas had an in-frame deletion in ATP2B3 resulting in the loss of two amino acids that overlapped with the other two deletions (c.1277_1282delTCGTGG; p.Val426_Val427del). Targeted sequencing of the 6 affected genomic positions in 199 additional adenomas identified 7 further somatic mutations in ATP1A1 and 1 in ATP2B3. The complete collection of APA samples (n = 308) contained 21 (6.8%) ATP1A1 or ATP2B3 mutations and 118 (38.3%) KCNJ5 mutations (Supplementary Table 4) . Concomitant KCNJ5 and ATP1A1 or ATP2B3 mutations within the same tumor were not observed.
None of the six different mutations were present in 1,600 in-house exomes or in the 1000 Genomes Project data set. In addition, the two missense mutations were not present in the Exome Variant Server data set (v.0.0.14). Although one of the ATP1A1 mutations, c.311T>G, is listed in dbSNP, it is only described as a non-validated candidate SNP derived from EST data and thus is rather unlikely to represent a germline variant. Exome and Sanger sequencing of the somatic mutations indicated that both the reference and alternative alleles were present in tumor tissue. This observation is consistent with a heterozygous state in individuals of both sexes with the ATP1A1 mutations and in females with the ATP2B3 mutations. Because ATP2B3 is located on the X chromosome, these findings suggest a polyclonal tumor composition in the case of the two males with ATP2B3 mutations. In fact, polyclonal composition has been well recognized as a feature of small adrenal adenomas 6, 7 . No ATP1A1 and ATP2B3 mutations were found in germline or adjacent normal adrenal samples within our group of APA cases. Of note, no germline alterations in these ATPase were found in a cohort of 18 subjects with familial aldosteronism type 2 (ref. 8) or in 91 sporadic cases with bilateral adrenal hyperplasia. In the normal adrenal samples, ATP1A1 was highly expressed in the zona glomerulosa and, to a lesser extent, in zona fasciculata, whereas ATP2B3 immunoreactivity was similarly detectable in all three layers of the adrenal cortex. ATP1A1 and ATP2B3 expression at the mRNA and protein levels was similar in APAs and in normal adrenal tissue. Similarly, within the APA group, ATP1A1 and ATP2B3 mRNA levels were found to be independent of the tumor's mutational status (Supplementary Fig. 2) .
The function and structure of the Na + /K + ATPase, of which the a subunit is encoded by ATP1A1, have been unraveled in exquisite detail over the last decades 9 . For each ATP being hydrolyzed, ATP1A1 exchanges three cytoplasmic sodium ions for two extracellular potassium ions 10 The calcium ion is shown together with the liganding residues (Val304, Glu309, Asn796 and Asp800). Val304 in M4 is equivalent to the valine that, together with a juxtaposed leucine, is deleted in the ATP2B3 mutant. Glu309 is equivalent to Glu334 of the Na + /K + ATPase. npg l e t t e r s ion fluxes that generate resting membrane potential and action potentials. Through site-directed mutagenesis and in vitro assays, individual domains within the Na + /K + ATPase a1 subunit have been associated with specific functional properties 11 . Notably, there is good evidence for a direct link between Na + /K + ATPase and the regulation of aldosterone secretion: blockade of Na + /K + ATPases with the specific antagonist ouabain results in dose-dependent stimulation of aldosterone release from glomerulosa cells 12 and glomerulosa cell growth in vivo 13 . Furthermore, angiotensin II lowers Na + /K + ATPase activity, indicating the potential contribution of this enzyme to angiotensin-dependent aldosterone release 14 . Notably, heterozygous Atp1a1 knockout mice are characterized by higher serum aldosterone concentrations compared to wild-type littermates 15 , although indirect effects might well apply to this phenotype. However, up until now, no germline or somatic ATP1A1 mutations have been associated with human disease. ATP2B3 also belongs to the ATPase gene family and encodes a plasma membrane Ca 2+ ATPase (ATP2B3, also known as PMCA3) that is essential to clear calcium ions from the cytoplasm of eukaryotic cells and thereby has a critical role in intracellular calcium homeostasis 16 . Although several mutations of the genes encoding ATP2B2 (also known as PMCA2) have been identified in mouse models 17 and humans with hearing loss 18 , no mutations in ATP2B3 have been described as causative for human disease. Projection of the ATP1A1 alterations onto the resolved crystal structure of the orthologous Squalus acanthias Na + /K + ATPase ( Fig. 2 and Supplementary Fig. 1b) showed that all three alterations are either located in the transmembranous a helix M1 or the juxtaposed a helix M4, which have been suggested to interact and cooperate in potassium ion binding and gating by interaction of Glu334 with Leu104 (ref. 11). As the atomic structure of the plasma membrane Ca 2+ ATPase ATP2B3 has not yet been determined, we used the known structure of the homologous rabbit sarcoplasmic reticulum type Ca 2+ ATPase (SERCA) to localize the ATP2B3 alterations. Notably, the APA-associated deletion mutations in ATP2B3 also alter the M4 transmembrane helix in the same region where the glutamate homologous to Glu334 of ATP1A1 is positioned (Fig. 2) . In SERCA, this glutamate is a crucial residue in calcium ion binding (Fig. 2d) . Therefore, the deletion in ATP2B3 is predicted to cause a major distortion of the calcium ion binding site. The recurrence of mutations affecting these highly conserved regions involved in interaction with the transported cations in two paralogs is suggestive of a gain-of-function effect.
To examine the functional consequences of the p.Leu104Arg and p.Val332Gly alterations of ATP1A1, we transfected COS cells with the corresponding mutated ouabain-insensitive rat cDNA and subjected them to selection in the presence of ouabain, thereby inhibiting the endogenous enzyme in COS cells 11 . No viable colonies were detected, indicating that the physiological Na + /K + pump activity of the mutant rat enzymes was very low or nonexistent. We therefore expressed the mutants transiently in COS cells in the presence of small interfering RNA (siRNA) binding specifically to the endogenous COS cell Na + /K + ATPase a subunit mRNA, thus knocking down the endogenous Na + /K + ATPase. This allowed us to carry out in vitro enzymatic studies of expressed mutant and wild-type Atp1a1. The ATPase activity determined under optimal conditions for wild-type Atp1a1 was indeed undetectable for the Leu104Arg variant and very low for the Val332Gly variant (Fig. 3a) . However, the mutant enzymes were well expressed and able to react with ATP and be phosphorylated in a sodium iondependent reaction (Fig. 3b) . Notably, the detected affinity for potassium ion was conspicuously lower in the mutants relative to wild-type l e t t e r s Atp1a1 (~0.2% and 2% for the Leu104Arg and Val332Gly mutants, respectively; Fig. 3c ). The effect of the p.Leu104Arg mutation supports the previous suggestion that Leu104 by van der Waals interaction positions Glu334, which is essential for potassium ion binding and gating of the binding pocket 11 . Substitution of the almost-juxtaposed Val332 with a glycine, which lacks a side chain, may create flexibility, likewise disturbing the function of Glu334 (Fig. 2a-c) .
Under ex vivo conditions, electrophysiological examination of primary cultured adenoma cells with different underlying mutations showed substantially higher levels of depolarization in ATPase (ATP1A1 or ATP2B3)-mutant cells compared to cells from normal adjacent tissue. This indicates that adenoma cells with mutations in ATPase genes have profoundly altered electrophysiological properties. The finding was specific for ATPase-mutant adenoma samples, as such a strong depolarization was not observed in KCNJ5-mutant adenoma samples or in adenoma cells without known mutation (Fig. 3d) . When extracellular sodium ions were removed, primary cells hyperpolarized, suggesting a disturbed intracellular ion composition and/ or loss of net charge transport by the mutated pump (Fig. 3e) . As expected, the hyperpolarization was most pronounced in cells from adenomas with mutant sodium ion-permeable KCNJ5 (ref. 4) . The effect of sodium ion removal in primary adenoma cells with mutant ATP1A1 was less marked. This suggests that the strong depolarization observed in cells with mutant ATP1A1 is not primarily caused by higher channel-like sodium ion conductance but possibly by disturbed intracellular ion composition (Fig. 3e) . In HEK cells transfected with cDNA for the Leu104Arg variant of Atp1a1, the membrane voltage was depolarized compared to cells expressing wild-type Atp1a1, suggesting that the depolarization of primary adenoma cells is a specific consequence of the mutation of ATP1A1 (Fig. 3f) .
Whereas KCNJ5 mutations have been consistently reported to be more prevalent in female cases 5, 19, 20 , ATPase alterations were predominantly found in males (81.0% (17/21) of cases with either ATP1A1 or ATP2B3 mutation were male versus 25.4% (30/118) of cases with KCNJ5 mutation; P < 0.0001). Consistent with a more severe phenotype, individuals with ATPase-mutant tumors had higher preoperative aldosterone concentrations (median of 397.8 ng/l, interquartile range of 555.0 ng/l versus median of 286.6 ng/l, interquartile range of 287.2 ng/l in cases without mutations; P = 0.02) and significantly lower serum potassium concentrations (median of 2.6 mM, interquartile range of 0.8 mM versus median of 3.1 mM, interquartile range of 0.8 mM in cases with KCNJ5 mutations; P = 0.013). Other clinical endpoints, including tumor size, blood pressure, serum sodium concentration and urinary albumin secretion, were similar between the groups (Supplementary Table 5) .
We have been unable to detect germline mutations in ATP1A1 or ATP2B3 in individuals with familial forms or with the bilateral form of primary aldosteronism. Given the central role of the Na + /K + ATPases and Ca 2+ ATPases in generating the electrochemical gradients required for electrical excitability and the cellular uptake of ions, nutrients and neurotransmitters, as well as for the regulation of cell volume and intracellular pH, germline mutations in these genes are predicted to be under strong purifying selection. Notably, however, ATP2B1, encoding one of the four mammalian plasma membrane Ca 2+ ATPase isoforms, was significantly associated with systolic and diastolic blood pressure and hypertension in a recent genome-wide association study 21 .
In summary, we show here that somatic mutations in ATP1A1 and ATP2B3 are present in roughly 7% of aldosterone-producing adenomas. In both instances, inactivation of the pump function, either indirectly (in the case of ATP1A1) or directly (in the case of ATP2B3) is predicted to increase intracellular calcium ion concentrations, which in turn prime calcium-dependent signaling and aldosterone output (Fig. 4) . As the alterations identified in both ATPases are constrained to specific and highly conserved functional domains, further gainof-function mechanisms, such as a pathological transport mode, might be potential contributors to the molecular phenotype. Thus, these findings expand the spectrum of somatic alterations leading to APAs to two members of the P-type ATPase pump family, extend knowledge of the molecular mechanism leading to APAs and indicate new potential therapeutic targets for the most frequent secondary form of arterial hypertension. Nucleic acid extraction. DNA or RNA was extracted from a total of 308 APAs with 17 paired peritumoral adrenal cortices and 16 peripheral DNA samples in addition to 91 peripheral DNA samples from subjects with bilateral adrenal hyperplasia. Tumor DNA was extracted using the RNeasy DNA extraction kit (Qiagen); DNA from peripheral blood leukocytes was prepared using salt extraction. Total RNA was isolated from frozen tissue using TRIzol (Invitrogen) and then cleaned on silica columns using the RNeasy Mini kit (Qiagen). RNA integrity and quality were systematically checked using an Agilent 2100 Bioanalyzer with the RNA6000 Nano Assay (Agilent Technologies). After DNase I treatment (Invitrogen), 500 ng of total RNA was reverse transcribed using Superscript II reverse transcriptase (Invitrogen) and random hexamers (Promega).
Exome sequencing. Exomes were enriched in solution and indexed with SureSelect XT Human All Exon 50 Mb kits (Agilent). Sequencing was performed as 100-bp paired-end runs on HiSeq2000 systems (Illumina). Pools of 12 indexed libraries were sequenced on 4 lanes. Image analysis and base calling were performed using Illumina Real Time Analysis. CASAVA 1.8 was used for demultiplexing.
Variant detection. Burrows-Wheeler Aligner (BWA v 0.5.9) with standard parameters was used for read alignment against the human genome assembly hg19 (GRCh37). We performed single-nucleotide variant and small insertion and deletion (indel) calling specifically for the regions targeted by the exome enrichment kit using SAMtools (v 0.1.18). Subsequently, variant quality was determined using the SAMtools varFilter script. We used default parameters, with the exception of the maximum read depth (-D) and the minimum P value for base quality bias (-2), which we set to 9,999 and 1 × 10 −400 , respectively. Additionally, we applied a custom script to mark all variants with adjacent bases of low median base quality. All variants were then annotated using custom Perl scripts. Annotation included information about known transcripts (UCSC Known Genes and RefSeq genes), known variants (dbSNP v135), type of mutation and, if applicable, amino-acid change in the corresponding protein. Annotated variants were then added to our in-house database.
To discover putative somatic variants, we queried our database to show only those variants of a tumor that were not found in the corresponding control tissue. To reduce the number of false positives, we filtered out variants that were already present in our database, had variant quality of less than 40 or did not pass one of the filters from the filter scripts. We then manually investigated the raw read data of the remaining variants using the Integrative Genomics Viewer (IGV).
ATP1A1 and ATP2B3 sequencing. DNA was amplified using intron-spanning primers. Bidirectional Sanger sequencing was performed using the ABI BigDye Terminator v.3.1 Cycle Sequencing kit. Primer sequences (available on request) were designed using Primer3 or ExonPrimer software.
Protein sequence analysis. Similarity analysis was performed using the ClustalW2 program. Human ATP1A1 (NP_000692.2) and ATP2B3 (NP_068768) sequences were compared with sequences from other species and with those of other human ATPases, respectively.
Modeling of protein structures. Structural representations were prepared using PyMOL software. The Na + /K + ATPase and sarcoplasmic reticulum Ca 2+ ATPase structures shown have Protein Data Bank (PDB) accessions 2ZXE and 1SU4, respectively.
Immunohistochemistry. Immunohistochemistry was performed on sections deparaffinized in xylene and rehydrated through graded ethanol. For antigen unmasking, slides were incubated in antigen unmasking solution (Vector Laboratories) for 30 min at 98 °C. Endogenous peroxidases were inhibited by incubation in 3% hydrogen peroxide (Sigma-Aldrich) in water for 10 min, and nonspecific staining was blocked with normal goat serum. Primary antibodies (ATP1A1: Abgent, AJ1524a; 1:1,000 dilution; ATP2B3: Sigma-Aldrich, HPA001583; 1:100 dilution) were incubated with sections overnight at 4 °C. Sections were washed, incubated for 30 min with affinity-purified goat secondary antibody to rabbit (Vector Laboratories; 1:400 dilution), washed and incubated with an avidin-biotin-peroxidase complex (Vectastain ABC Elite, Vector Laboratories) for 30 min. Slides were developed using diaminobenzidin (Vector Laboratories) and counterstained with hematoxylin (Sigma). In the negative control reactions, primary antibodies were omitted from the dilution buffer, which in all instances resulted in a complete absence of staining. All microscopic examinations were carried out on a Leica microscope. Quantification was performed on 3 different fields per tumor in 3 ATP1A1-mutant APAs and 14 non-mutant APAs. Results represent the means ± s.e.m. of 135-215 cells expressed as the percentage for each expression pattern.
Quantification of mRNA expression. mRNA expression data for 91 samples with genotype data were retrieved from a pangenomic transcriptome analysis performed on 123 samples collected through the COMETE network from patients operated on for APA between 1994 and 2008 in the Hypertension Unit at the Hôpital Européen Georges Pompidou in Paris. Procedures for data acquisition and calculation have been described in detail elsewhere 5 .
Quantification of Na + /K + ATPase activity in transfected cells. For in vitro studies, mutations were introduced into the full-length cDNA encoding the ouabain-resistant rat a1 isoform of the Na + /K + ATPase Atp1a1, and the mutant and wild-type constructs were expressed in COS-1 cells. The >100-fold difference between the ouabain affinities of exogenous rat Atp1a1 and the endogenous COS-1 cell ATP1A1 enzyme allows isolation of stable cell lines under ouabain selection pressure, provided that the exogenous enzyme is functional in sodium and potassium ion pumping. Because the mutants studied here were unable to support cell growth in the presence of ouabain, thus indicating lack of pump function, we also used siRNA cotransfection to knock down the endogenous enzyme, thereby allowing studies of transiently expressed enzyme as an alternative. Leaky plasma membranes were assayed functionally using previously described methods 11 . Na + /K + ATPase activity was determined at 37 °C by following the liberation of inorganic phosphate (P i ) in the presence of 130 mM NaCl, 20 mM KCl, 3 mM MgATP, 30 mM histidine buffer (pH 7.5) and 1 mM EGTA, together with 100 µM ouabain to ensure complete knockout of the ouabain-sensitive endogenous enzyme. Phosphorylation was carried out for 10 s at 0 °C with 2 µM [γ-32 P] ATP in the presence of 100 mM NaCl, 3 mM MgCl 2 , 20 mM Tris (pH 7.5), 100 µM ouabain and 20 µg/ml oligomycin or in the presence of 50 mM NaCl, 3 mM MgCl 2 , 20 mM Tris (pH 7.5), 100 µM ouabain and varying concentrations of KCl, with choline chloride added to maintain constant ionic strength. The [ 32 P]-labeled Na + /K + ATPase was separated by acid SDS gel electrophoresis, and radioactivity was quantified by phosphorimaging. For quantification, the number of replicates was n = 4-6. Background activity, represented by the inactive phosphorylation site Atp1a1 mutant Asp376Asn, was subtracted in all cases.
Preparation of primary cell cultures. For primary cultures from APAs and adjacent normal adrenal gland tissue, samples were cleaned of surrounding fat, connective tissue and blood vessels. Then, tissue samples were minced into pieces smaller than 0.5 mm using a razor blade. Minced samples were transferred to 15-ml Falcon tubes and spun down at 225g for 5 min. The pellet was resuspended in 10 ml of digestion buffer containing 2 mg/ml of collagenase II (Biochrom) in PBS and incubated at 37 °C for no longer than 50 min in a shaking water bath. Every 15 min, tube content was pipetted npg up and down several times using 25-ml and, subsequently, 10-ml pipettes to support digestion. Collagenase was inactivated by adding pure FCS to a minimum total concentration of 10%, and cells were sequentially filtered through 100-µm and 70-µm nylon mesh and centrifuged as above. The pellet was resuspended in erythrocyte lysis buffer and incubated for 7 min at room temperature. After another centrifugation step, cells were resuspended in 1-2 ml of culture medium, depending on the expected cell count (DMEM/F12 with 10% FCS, 3.1 g/l glucose and 10 µl/ml penicillin-streptomycin, all from Gibco) and filtered through 70-µm nylon mesh. Cell number was determined using a Neubauer counting chamber.
Electrophysiological evaluation of primary cell cultures and transfected cells. Patch clamp recordings were performed using an EPC-10 amplifier without leak subtraction (HEKA). The solution (pH 7.4) for primary adenoma cells contained 5 mM HEPES, 124.5 mM NaCl, 1.6 mM Na 2 HPO 4 , 0.4 mM NaH 2 PO 4 , 5 mM glucose; 1 mM MgCl 2 , 1.3 mM CaCl 2 and 4.1 mM KCl. The extracellular solution for voltage measurements in HEK cells contained 5 mM HEPES, 145 mM NaCl, 1.6 mM K 2 HPO 4 , 0.4 mM KH 2 PO 4 , 5 mM glucose, 1 mM MgCl 2 and 1.3 mM CaCl 2 . For the sodium ion-free solution, sodium was replaced by N-methyl-d-glucamine. The pipette solution (pH 7.2) contained 95 mM potassium gluconate, 30 mM KCl, 4.8 mM Na 2 HPO 4 , 1.2 mM NaH 2 PO 4 , 5 mM glucose, 2.3 mM MgCl 2 , 0.762 mM CaCl 2 , 1 mM EGTA and 3 mM Na 2 ATP. For functional expression in HEK cells, the full-length cDNAs of wild-type rat Atp1a1 and mutant Atp1a1 Leu104Arg were subcloned into the bicistronic pIRES-CD8 expression vector. One day before voltage measurements, HEK cells were transfected with the constructs for wild-type rat Atp1a1 or the Atp1a1 Leu104Arg mutant using Lipofectamine. Dynabeads labeled with antibody to CD8 (Invitrogen) were used to identify transfected cells.
Statistical analysis.
If not stated otherwise, group results are expressed as median values with interquartile ranges. Data between groups were compared using the Kruskal-Wallis test followed by a two-sided test for the pairwise comparison of two groups. The significance level of P < 0.05 was considered to indicate statistical significance. Statistical analysis was performed using standard statistical software (SPSS 20).
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